Your session is about to expire
← Back to Search
Intervention for Educational Activities (SUPPORT-Pro Trial)
N/A
Waitlist Available
Led By Anne-Sophie Brazeau, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
SUPPORT-Pro Trial Summary
This trial will help determine if the SUPPORT-Pro online training platform can increase health care professionals' confidence level in treating individuals with type 1 diabetes.
SUPPORT-Pro Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To compare the level of confidence in treating individuals with type 1 diabetes measured at 3 months to the level of confidence measured at baseline.
Secondary outcome measures
Number of completed categories
Number of completed courses
Number of posts of the discussion forum
+5 moreSUPPORT-Pro Trial Design
1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All participants partaking the SUPPORT-Pro study will receive the full intervention for 3 months which implies: (1) Full access to the platform (2) a newsletter sent by email every 2 weeks to inform them on the new blogs posted on the platform.
During the following 9 months, participants will still have access to the platform, but no newsletter will be sent (sustainability phase).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intervention
2011
Completed Phase 4
~73780
Find a Location
Who is running the clinical trial?
McGill UniversityLead Sponsor
392 Previous Clinical Trials
984,276 Total Patients Enrolled
Institut de Recherches Cliniques de MontrealOTHER
70 Previous Clinical Trials
10,139 Total Patients Enrolled
Anne-Sophie Brazeau, PhDPrincipal InvestigatorMcGill University
4 Previous Clinical Trials
1,181 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You work in the pharmaceutical industry.You have Type 1 Diabetes.You have worked with someone who has type 1 diabetes within the last six months and can tell us about your experience.You are currently living with someone who has type 1 diabetes.People who are certified to educate others about diabetes.You work at a specialized clinic for type 1 diabetes patients.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals are the maximum amount involved in this research project?
"Affirmative. The clinical trial, which was first published on May 13th 2021 and last revised on September 2nd 2022 is still recruiting participants according to the records hosted by clinicaltrials.gov. For this study, 100 individuals are required for enrolment at 1 site."
Answered by AI
Are there still opportunities to participate in this research experiment?
"Data on clinicaltrials.gov confirms that this trial, which was posted on May 13th 2021 and revised September 2nd 2022, is actively looking for qualified applicants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger